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It has been reported that Notch family proteins are expressed in synovium tissue and involved in the proliferation of synoviocyte
from rheumatoid arthritis (RA). The aim of this paper was to investigate whether Notch signaling mediated TNF-α-induced
cytokine production of cultured ﬁbroblast-like synoviocytes (FLSs) from RA. Exposure of RA FLSs to TNF-α (10ng/ml) led to
increase of Hes-1, a target gene of Notch signaling, and a marked upregulation of Notch 2, Delta-like 1, and Delta-like 3 mRNA
levels. Blockage of Notch signaling by a γ-secretase inhibitor (DAPT) inhibited IL-6 secretion of RA FLSs in response to TNF-α
while treatment with recombinant fusion protein of Notch ligand Delta-like 1 promoted such response. TNF-α stimulation also
induced IL-6 secretion in OA FLSs; however, the Hes-1 level remained unaﬀected. Our data conﬁrm the functional involvement of
Notch pathway in the pathophysiology of RA FLSs which may provide a new target for RA therapy.
1.Introduction
Rheumatoid arthritis (RA) is characterized by chronic and
progressive inﬂammation of multiple joints, resulting in
leukocyte invasion, formation of pannus, progressive deg-
radation of the cartilage, and erosion of the bones [1].
Although the exact mechanism of RA pathogenesis is not
welldeﬁned,ithasbeensuggestedthatactivatedsynoviocytes
may play an important role, primarily through proliferation
in inﬂamed synovia, and production of proinﬂammatory cy-
tokines, matrix metalloproteinases (MMPs), and chemoki-
nes [2]. Cytokines secreted by RA synoviocytes include
tumor necrosis factor-α (TNF-α), interleukin-1α (IL-1α),
interleukin-1β (IL-1β), interleukin-6 (IL-6), interleukin-8
(IL-8), and granulocyte macrophage-colony stimulating
factor (GM-CSF) [3]. Among these cytokines, TNF-α ap-
pears to be the major proinﬂammatory cytokine because
it is known to strongly induce the production of IL-6,
IL-8, GM-CSF, and even itself in synoviocytes; however, the
precise molecular mechanism of cytokines production in
response to TNF-α stimulation is not clariﬁed [4].
The Notch signaling pathway is highly conserved beyond
species and plays a critical role in a variety of cellular
functions, including cell proliferation, diﬀerentiation, and
apoptosis [5]. To date, four Notch receptors (Notch 1–4)
and ﬁve of their ligands (Delta-like 1, 3, 4; Jagged-1, 2)
have been identiﬁed in mammals. Upon ligand binding, the
intracellular domain (ICD) of the receptor is proteolytically
cleaved and translocated into the nucleus, where it associates
withtheRBP-Jκtranscriptionfactorandregulatesexpression
of several target genes, such as the basic helix-loop-helix
(bHLH) proteins hairy-enhancer of split-like 1- (Hes-1) and
Hes-5 [6].
Several early reports have shown the functional involve-
ment of Notch pathway in the pathophysiology of RA syno-
vitis. Ishii et al. and Yabe et al. showed that the expression
pattern of Notch homologues among synovium from OA
and RA patients diﬀered from that of normal subjects [7, 8].2 Clinical and Developmental Immunology
Another report demonstrated the expression of Notch-1 in
synoviocytes and the presence of Notch-1 fragment in the
nuclei of RA synoviocytes and suggested the involvement
of Notch-1 signaling in the TNF-α-induced proliferation
of RA synoviocytes [9]. TNF-α induced the expression
of IL-6, MMP11, Notch-1, Notch-4, and Jagged-2 in RA
FLSs [10, 11]. As yet, however, the expression pattern of
Notch molecules on cultured synoviocyte is controversial
and the relationship between increased expression of IL-6 or
MMP11 and Notch signaling molecules response to TNF-α-
stimulation remains unclear. In this study, we demonstrate
that Notch signaling mediates TNF-α-induced secretion of
IL-6 in RA FLSs while the expression pattern of Notch re-
ceptorsandligandsuponTNF-α-stimulationdiﬀersfromthe
previously reported.
2.MaterialsandMethods
2.1. Patients. Synovial tissue samples were obtained from
patients with RA (n = 4, one male, three females, the
mean age 54.7 ± 20.1) and OA (n = 3, one male, two
females, the mean age 51.3 ± 10.4) at the time of total knee
joint replacement. All RA patients fulﬁlled the respective
American Rheumatism Association criteria [12]. All OA
patients were evaluated by a certiﬁed rheumatologist and
diagnosed based on the criteria developed by the ACR
Diagnostic Subcommittee for OA [13]. Written consent
was obtained from all patients after a full explanation
of the procedure in conformity with requirements of the
Committee on Ethics of Biomedicine Research of Aﬃliated
Hospital of Jiangsu University.
2.2. Preparation of Fibroblast-Like Synoviocytes. RA FLSs
were isolated from synovial tissues according to the method
previously described [14]. Brieﬂy, the collected synovial
tissues were minced and cultured as explant pieces in a ﬂask.
Within 14 days, ﬁbroblast-like cells migrated out from the
tissue explants and formed conﬂuent monolayers. The cells
were collected by trypsinization and reseeded into ﬂasks for
expansion at 37◦Ci nD u l b e c c o ’ sm o d i ﬁ e dE a g l em e d i u m
(Gibco, BRL, USA) supplemented with 10% heat inactivated
fetal calf serum (Gibco, BRL, USA), 100units/mL penicillin,
and 100μg/mL streptomycin. Fibroblasts between passages
3 and 5 were used for each experiment after being identiﬁed
bymorphologyandpurityanalysis.Osteoarthritis(OA)FLSs
were similarly prepared.
2.3. Treatment of FLSs with TNF-α and Notch Inhibitor and
Ligand Fusion Protein. For kinetic analysis of the TNF-α-
inducedexpression ofNotch targetgeneHes-1andcytokines
production, 1 × 105 FLSs per well were seeded into 12-
well culture plates and subsequently stimulated with TNF-
α (10ng/mL, R&D Systems, Abingdon, UK) for various
times. After stimulation, culture supernatants were collected
and kept at −80◦C for the measurement of IL-6 and IL-
8 by ELISA, while the cells were lysed in TRIzol reagent
(Invitrogen, Carlsbad, CA, USA) for RNA isolation. To
observe the eﬀect of Notch signaling in the TNF-α-induced
cytokine production, a Notch inhibitor, DAPT (Sigma, St.
Louis,MO,USA)andNotchligandfusionprotein,Delta-like
1 (R&D Systems, Abingdon, UK), were also added into the
culture system together with TNF-α.
2.4. Measurement of IL-6 and IL-8 by ELISA. The concen-
trations of IL-6 and IL-8 in culture supernatants were deter-
mined by using commercial ELISA kits (eBioscience, San
Diego, USA) according to manufacturer’s recommendations.
2.5. RNA Isolation and Real-Time RT-PCR. For the deter-
mination of mRNA expression of Notch receptors, ligands
and target gene Hes1, total RNA was extracted from FLSs
with or without stimulation by using TRIzol reagent (In
vitrogen, Carlsbad, CA, USA). cDNA was prepared by re-
verse transcription with oligo (dT) from total RNA extrac-
tion. Real-time PCR for Notch signaling molecules and a
reference gene (β-actin) was performed in a LightCycler in-
strument (Roche Molecular Diagnostics, Mannheim, Ger-
many) with the SYBRgreen mastermix kit (Takara, Shiga,
Japan). The target gene expression was then normalized re-
lative to β-actin. Primers used were forward (5 -TCAGCG-
GGATCCACTGTGAG-3 )a n dr e v e r s e( 5  -ACACAGGCAG-
GTGAACGAGTTG-3 ) for Notch 1; forward (5 -TGCCAA-
GCTCAGTGGTGTTGTA-3 )a n dr e v e r s e( 5  -TGCTAGGC-
TTTGTGGGATTCAG-3 ) for Notch 2; forward (5 -GGT-
TCCCAGTGAGCACCCTTAC-3 )a n dr e v e r s e( 5  -GTGGA-
TTCGGACCAGTCTGAGAG-3 ) for Notch 3; forward (5 -
ACCTGCTCAACGGCTTCCA-3 )a n dr e v e r s e( 5  -AGCTT-
CTGCACTCATCGATATCCTC-3 ) for Notch 4; forward (5 -
ACCTGCTCAACGGCTTCCA-3 )a n dr e v e r s e( 5  -AGCTT-
CTGCACTCATCGATATCCTC-3 ) for Jagged-1; forward
(5 -ACCAGGTGGACGGCTTTGAG-3 )a n dr e v e r s e( 5  -
CCCGGGATGCAATCACAGTAATA-3 )f o rJ a g g e d2 ;f o r -
ward (5 -TGGGCTACTCCGGCTTCAAC-3 )a n dr e v e r s e
(5 -ACAGGTAGGCATCACCGAGGTC-3 ) for Delta-like 1;
forward (5 -TCAACAACCTAAGGACGCAGGAG-3 )a n d
reverse (5 -CTACATCTTCAGGGCGATTCCAA-3 )f o rD e l -
ta-like 3; forward (5 -GTCCAACTGTGGCAAACAGCA-3 )
and reverse (5 -AGCATATCGCTGATATCCGACACTC-3 )
for Delta-like 4; forward (5 -GACTGTGAAGCACCTCCG-
3 )a n dr e v e r s e( 5  -GTCATGGCGTTGATCTGG-3 )f o r
Hes1; forward (5 -GAAGTCCCTCACCCTCCCAA-3 )a n d
reverse (5 -GGCATGGACGCGACCA-3 )f o rβ-actin.
2.6. Statistical Analysis. Two-tailed Student’s t-test was used
for determining signiﬁcant diﬀerences (P ≤ 0.05) between
groups.
3. Results
3.1. TNF-α Stimulation Induces the Activation of Notch Sig-
naling in Fibroblast-Like Synoviocytes (FLS) from RA. We
ﬁrst determined the eﬀect of TNF-α on the expression of
Notch signaling molecules in RA FLSs by real-time PCR.
Exposure of RA FLSs to TNF-α led to a gradual, time-
dependent increase of Hes-1 mRNA levels, a target geneClinical and Developmental Immunology 3
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Figure 1: TNF-α stimulation induces the mRNA expression of Notch signaling molecules in ﬁbroblast-like synoviocytes (FLS) from RA.
(a) FLSs from 4 RA patients were cultured in the presence of TNF-α (10ng/mL) for 0, 4, 8, 16, 24, or 36h, and then analyzed for Hes-1
expression by PCR; (b) FLSs from 4 RA patients were cultured in the presence of TNF-α (10ng/mL) for 24h, followed by analysis of Notch
receptors expression by PCR; (c) FLSs from 4 RA patients were cultured in the presence of TNF-α (10ng/mL) for 24h, and then analyzed
for Notch ligands expression by PCR; J1: Jagged 1; J2: Jagged 2; D1: Delta-like 1; D3: Delta-like 3; D4: Delta-like 4. Results were normalized
to unstimulated condition (basal value = 1). Each column is the mean ± SD. ∗P<0.05 for unstimulated group versus TNF-α-stimulated
group.
of Notch signaling, which reached a maximum after 16–
24h of stimulation (Figure 1(a)). mRNAs of four receptors
and ﬁve ligands of Notch signaling were also detected in
RA FLSs stimulated with TNF-α (10ng/mL) for 24h. As
shown in Figure 1(b),T N F - α stimulation induced a marked
upregulation of Notch 2, in contrast, the levels of other
three receptors were unchanged. TNF-α also signiﬁcantly
increased the mRNA expression of two ligands, Delta-like
1 and Delta-like 3, while the expression of the other three
ligandswasnotaﬀected(Figure 1(c)).Thesedatasuggestthat
Notch signaling is activated upon TNF-α stimulation in RA
FLSs.
3.2.NotchSignalingMediatesTNF-α-InducedIL-6Production
in FLSs from RA. TNF-α stimulation induced a marked
secretion of IL-6 and IL-8 from RA FLSs, which reached
a maximum at 24h of stimulation (Figure 2(a)). To test
whether the activated Notch signaling mentioned above
mediatesthisprocess,weﬁrstdeterminedtheeﬀectofDAPT,
a Notch signaling inhibitor, on TNF-α-stimulated cytokines
secretion.Coincubationwithsuchblockingreagentinhibited
IL-6 secretion in response to TNF-α in a dose-dependent
manner; however, DAPT did not signiﬁcantly reduce the
IL-8 secretion (Figure 2(b)). To conﬁrm a role of Notch
signaling as a mediator of TNF-α-induced IL-6 secretion, we
examined the eﬀect of human recombinant fusion protein of
Notch ligand Delta-like 1 on TNF-α-induced IL-6 secretion.
As demonstrated in Figure 2(c), when Delta-like 1 protein
was added together with TNF-α, augmentation of IL-6
production was observed in a time-dependent manner. The
facilitation of Delta-like 1 protein on IL-6 secretion was
also dose-dependent with maximal response at 10μg/mL
(Figure 2(d)).
3.3. Eﬀect of TNF-α Stimulation on IL-6 and Hes-1 Production
in OA FLSs. To test whether Notch signaling could also
mediate IL-6 production in OA FLSs, we determined the
ability of TNF-α to induce IL-6 secretion and Hes-1 mRNA
expression in primary human OA FLSs. The spontaneous
secretion of IL-6 in cultured OA FLSs was signiﬁcantly lower4 Clinical and Developmental Immunology
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Figure 2: Notch activity contributes to TNF-α-induced IL-6 production of FLSs from RA. (a) FLSs from 4 RA patients were cultured in
the presence of TNF-α (10ng/mL) for 0, 4, 8, 16, 24, or 36h, and then measured the levels of supernatant IL-6 and IL-8 by ELISA; (b) RA
FLSs were cultured in the presence of TNF-α (10ng/mL) in addition to the indicated concentration of DAPT (Notch signaling blocking
reagent) for 24h. Supernatant IL-6 and IL-8 were determined by ELISA; (c) RA FLSs were cultured in the presence of TNF-α (10ng/mL)
in addition to Delta-like 1 fusion protein (10μg/mL) for indicated times. Supernatant IL-6 was determined by ELISA; (d) RA FLSs were
cultured in the presence of TNF-α (10ng/mL) in addition to indicated concentrations of Delta-like 1 fusion protein for 24h. Supernatant
IL-6 was determined by ELISA. Values are the mean ± SD.
than that of RA FLSs, while TNF-α stimulation induced
marked IL-6 secretion in both OA FLSs and RA FLSs
(Figure 3(a)). The basal Hes-1 mRNA expression in OA FLSs
was also signiﬁcantly lower than that of RA FLSs; however,
unlike in RA FLSs, TNF-α stimulation did not increase the
Hes-1 mRNA expression in OA FLSs (Figure 3(b)). This
result indicates that involvement of Notch signaling in TNF-
α-induced IL-6 production should be unique to RA FLSs.
4. Discussion
Fibroblast-like synoviocytes, (FLSs) also called synovial
ﬁbroblasts (SF), are resident mesenchymal cells of synovial
joints [15]. Activation of FLSs in the setting of RA leads
to the production of a variety of cytokines, small molecule
mediators of inﬂammation, and proteolytic enzymes which
are responsible for the progressive destruction of articular
cartilage and bone [4, 10]. Activation of FLSs could be
initiated by cytokines, among which TNF-α is paramount.
Activated FLSs by TNF-α in turn produce IL-6, IL-1β,
and even itself to sustain regulatory feedback loops that
perpetuate local joint inﬂammation. Such mechanism has
been conﬁrmed by the clinical eﬃcacy of TNF-α blocking
reagent in the treatment of RA synovitis. However, it
remains less clear how many signal pathways are activated
w i t h i nF L S su p o nT N F - α stimulation, and therefore which
signal pathway may be the alternative target for clinical
intervention.
Several early studies, which reported the expression of
Notch molecules in RA synovium and the involvement of
Notch signaling in the activation of cultured FLSs [9, 11, 16],
led us to test the role of Notch signaling in the cytokineClinical and Developmental Immunology 5
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Figure 3: Eﬀect of TNF-α stimulation on IL-6 and Hes-1 production in OA FLSs. (a) OA and RA FLSs were incubated with TNF-α
(10ng/mL) for 24h, and then the supernatants were collected and analyzed for the IL-6 production by ELISA; (b) OA and RA FLSs were
incubated with TNF-α (10ng/mL) for 24h, and then the cells were collected and analyzed for the Hes-1 mRNA expression by PCR. Each
column is the mean ± SD. ∗P<0.05.
s e c r e t i o no fR AF L S si nr e s p o n s et oT N F - α stimulation.
The present study ﬁrst observed that TNF-α stimulation
led to a gradual, time-dependent increase of Hes-1 mRNA
levels in RA FLSs, which reached a maximum after 16–
24h of stimulation. Hes-1 is the most well characterized,
γ-secretase-dependent transcriptional target gene of Notch,
and upregulated expression of Hes-1 represents the activated
Notchsignaling.Apreviousstudyhasalsodemonstratedthat
TNF-α induced the elicitation of the Notch signaling by the
observation of nuclear translocation of Notch intracellular
domain (NICD) in cultured RA FLSs [9]. However, the
same study reported that TNF-α treatment (200pg/mL)
upregulated the expression of Notch 1, Notch 4, and Jagged
2, which is quite diﬀerent from our results that TNF-
α stimulation (10ng/mL) induced a marked upregulation
of Notch 2 and two ligands, Delta-like 1 and Delta-like
3. This diversity may be due to the diﬀerent stimulation
concentration of TNF-α used in experimental system or
the diﬀerent culture times. Indeed, the expression proﬁle
of Notch receptors or ligands in RA local synovium tissue
also varied among previous reports [7, 8, 11]. Nevertheless,
here we conﬁrmed the result that TNF-α could induce the
activation of Notch signaling in cultured RA FLSs.
TNF-α has been shown to induce cytokine production in
RA FLSs, such as IL-6 and IL-8 [3, 10, 11]. We also observed
the increased production of IL-6 and IL-8 upon TNF-α
stimulation, which was consistent with the previous reports.
FLSs in the intimal lining have been shown to be the primary
source of IL-6 by in situ hybridization and immunohisto-
chemistry studies. Cultured RA FLSs spontaneously produce
IL-6, and their production is markedly increased by TNF-α,
thus, targeting the function of FLSs to produce IL-6 might
improve clinical outcomes in inﬂammatory arthritis without
suppressing systemic immunity [3, 10].
To test whether the activated Notch signaling mediate
the cytokine production in response to TNF-α stimulation,
DAPT, a γ-secretase inhibitor, was added into the culture
system to block the activation of Notch signaling. We found
that DAPT inhibited IL-6 secretion in response to TNF-α in
a dose-dependent manner, however, it did not signiﬁcantly
reduce the IL-8 secretion. To conﬁrm a role of Notch signal-
ing as a mediator of TNF-α-induced IL-6 secretion, we also
demonstratedthatDelta-like1fusionproteinaddedtogether
withTNF-α, augmented IL-6 production in a time and dose-
dependent manner. In our study, TNF-α stimulation could
also induce marked IL-6 secretion in OA FLSs other than
RA FLSs. However, unlike in RA FLSs, TNF-α stimulation
did not increase the Hes-1 mRNA expression in OA FLSs.
Such inconsistent result indicated that the targets of Notch-
mediatedtranscriptional activationshouldbeexploredother
than Hes-1. Alternatively, there may be target sequences of
CSL in the IL-6 promoter. Similar research strategies had
been reported in a newly published paper [17]. By ChIP
analysis, Keerthivasan et al. report NICD directly binds
to both ROR-γt and IL-17 promoters and regulates Th17
diﬀerentiation(IL-17induction).Furtherexperimentationis
required to test whether Notch can bind directly to the IL-6
promoters.
The function of FLSs to produce IL-6 has been reported
to be regulated in an NF-κB-dependent pathway. In fact,
some eﬀective anti-RA drugs are now known to inhibit NF-
κB and its activation cascade. Here we reported that Notch
signaling also mediated TNF-α-induced IL-6 production
in cultured RA FLSs which can also potentially serve as
therapeutic target signaling. We have also demonstrated the
activation of Notch signaling in helper T cells from RA
patients [18]. Based on these considerations, using inhibitors
of γ-secretase (as is already in use for the treatment of6 Clinical and Developmental Immunology
Alzheimer’s disease) to block the activated Notch signaling
might be a feasible approach to RA therapy [19].
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